KMDA

KAMADA LTD

Healthcare · Drug Manufacturers - Specialty & Generic

$56.80 sample

+0.09 (+0.16%) 1D

Market cap

$143.3B

Price as of

2026-10-04

Latest filing

8-K · 2026-09-28

Alerts

8

Price$56.80 -2.69% 3M daily closessample

58.3854.86

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28SECDEF 14A filed
Sep 18INSInsider sell: Director
Sep 11SEC10-Q filed
Sep 02INSInsider sell: General Counsel
Aug 25INSInsider buy: Chief Financial Officer
Aug 14INSInsider buy: EVP, Operations
Aug 05INSInsider buy: Chief Financial Officer
Jul 30INSInsider buy: Director

Sign up to see the real KMDA record →

Company facts

SEC EDGAR registration

Name: KAMADA LTD
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Smart-money score: -34sample, -100 to +100
Reporting currency: USD

Who is positioning in KMDA

sample

Insiders: 27 insider transactions over 90 days, net selling, $874.0M
Congress: 2 members traded over 90 days
Institutions · 13F: 21 funds hold $1.3B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$3.9B +15.3% y/y

Q4 2024Q3 2026

Inventory$2.3B +8.8% y/y

Q4 2024Q3 2026

Accounts receivable$1.8B +20.0% y/y

Q4 2024Q3 2026

Total debt$4.9B +14.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $55.3B -1.0% 3M
Sample peer B: $83.1B +11.1% 3M
Sample peer C: $82.6B +7.8% 3M
Sample peer D: $65.9B -5.5% 3M
Sample peer E: $78.4B +4.6% 3M